BR9812240A - Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica - Google Patents
Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênicaInfo
- Publication number
- BR9812240A BR9812240A BR9812240-1A BR9812240A BR9812240A BR 9812240 A BR9812240 A BR 9812240A BR 9812240 A BR9812240 A BR 9812240A BR 9812240 A BR9812240 A BR 9812240A
- Authority
- BR
- Brazil
- Prior art keywords
- rsv
- protein
- altered
- vertebrate
- composition
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 9
- 108090000623 proteins and genes Proteins 0.000 title abstract 9
- 239000000203 mixture Substances 0.000 title abstract 8
- 241000251539 Vertebrata <Metazoa> Species 0.000 title abstract 7
- 230000002163 immunogen Effects 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 102000039446 nucleic acids Human genes 0.000 title abstract 4
- 108020004707 nucleic acids Proteins 0.000 title abstract 4
- 150000007523 nucleic acids Chemical class 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title abstract 3
- 238000002255 vaccination Methods 0.000 title abstract 3
- 230000028993 immune response Effects 0.000 title abstract 2
- 230000006698 induction Effects 0.000 title abstract 2
- -1 use of it Proteins 0.000 title abstract 2
- 238000010276 construction Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 108091006027 G proteins Proteins 0.000 abstract 2
- 102000030782 GTP binding Human genes 0.000 abstract 2
- 108091000058 GTP-Binding Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 206010035664 Pneumonia Diseases 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000005847 immunogenicity Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000009732 pulmonary eosinophilia Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5968497P | 1997-09-19 | 1997-09-19 | |
| US8486398P | 1998-05-08 | 1998-05-08 | |
| PCT/US1998/019656 WO1999014334A1 (en) | 1997-09-19 | 1998-09-17 | Peptides derived from the attachment (g) protein of respiratory syncytial virus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9812240A true BR9812240A (pt) | 2000-07-18 |
Family
ID=26739056
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9812240-1A BR9812240A (pt) | 1997-09-19 | 1998-09-17 | Proteìna g alterada ou polipeptìdeo do rsv, uso da mesma, molécula de ácido nucleico codificando uma proteìna g alterada ou um polipeptìdeo do rsv, construção do ácido nucleico, célula hospedeira recombinante, processos de produção de uma proteìna g alterada ou polipeptìdeo do rsv composição imunogênica, de indução de uma resposta imune em um vertebrado, de inibir a indução do aumento da doença após a vacinação e subsequente infecção de um vertebrado com o rsv e de imunização de um vertebrado contra o rsv, composição de vacina, vacina, e, composição imunogênica |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1015595B1 (enExample) |
| JP (1) | JP2001516583A (enExample) |
| KR (1) | KR100550132B1 (enExample) |
| CN (1) | CN1259422C (enExample) |
| AT (1) | ATE287957T1 (enExample) |
| AU (1) | AU751022B2 (enExample) |
| BR (1) | BR9812240A (enExample) |
| CA (1) | CA2302833C (enExample) |
| CY (1) | CY1105010T1 (enExample) |
| DE (1) | DE69828801T2 (enExample) |
| ES (1) | ES2236946T3 (enExample) |
| PT (1) | PT1015595E (enExample) |
| WO (1) | WO1999014334A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1334119B2 (en) | 2000-10-18 | 2018-11-28 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Compositions and methods for modulating rsv infection and immunity |
| AUPR520201A0 (en) * | 2001-05-23 | 2001-06-14 | Commonwealth Scientific And Industrial Research Organisation | Antiviral compounds |
| NL1019228C1 (nl) | 2001-10-25 | 2003-04-28 | Duynstee Holding B V | Verbeterd gecombineerd ophang- en verlichtingssysteem voor bijvoorbeeld schilderijen e.d. |
| US6667327B2 (en) | 2002-02-04 | 2003-12-23 | Hoffmann-La Roche Inc. | Pyridine amido derivatives |
| DE10219219A1 (de) | 2002-04-29 | 2003-11-06 | Tampoflex Gmbh | Druckanlage |
| WO2004092207A2 (en) * | 2003-04-16 | 2004-10-28 | Algonomics N.V. | Respiratory syncytial virus (rsv) peptides |
| US7368537B2 (en) * | 2003-07-15 | 2008-05-06 | Id Biomedical Corporation Of Quebec | Subunit vaccine against respiratory syncytial virus infection |
| RU2006117366A (ru) | 2003-10-23 | 2007-12-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Производные бензазепина в качестве ингибиторов мао-в |
| US7666433B2 (en) * | 2004-06-30 | 2010-02-23 | Wyeth Holdings Corporation | Recombinant RSV strains with altered G protein |
| EP2181121A4 (en) * | 2007-03-21 | 2012-07-11 | Id Biomedical Corp Quebec | CHIMÄRE ANTIGENE |
| US8563002B2 (en) | 2007-12-24 | 2013-10-22 | Glaxosmithkline Biologicals, S.A. | Recombinant RSV antigens |
| SG176807A1 (en) | 2009-06-24 | 2012-01-30 | Id Biomedical Corp Quebec | Vaccine |
| PL2445526T3 (pl) | 2009-06-24 | 2017-08-31 | Glaxosmithkline Biologicals S.A. | Rekombinowane antygeny rsv |
| EP4183412B1 (en) | 2009-07-15 | 2024-08-14 | GlaxoSmithKline Biologicals SA | Rsv f protein compositions and methods for making same |
| EP2453903B1 (en) * | 2009-07-17 | 2016-08-17 | Industry Academic Cooperation Foundation, Hallym University | Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes |
| US8846056B2 (en) | 2009-08-04 | 2014-09-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control | Anti-RSV immunogens and methods of immunization |
| RS56748B1 (sr) | 2011-05-13 | 2018-03-30 | Glaxosmithkline Biologicals Sa | Pre-fuzioni rsv f antigeni |
| EP3956351A1 (en) * | 2019-04-18 | 2022-02-23 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Biological and synthetic molecules inhibiting respiratory syncytial virus infection |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2726577B1 (fr) * | 1994-11-07 | 1997-01-31 | Pf Medicament | Procede d'obtention d'un peptide derive du virus respiratoire syncitial, polypeptide et bacterie l'exprimant, et leurs applications a titre de medicament |
| AU722494C (en) * | 1996-06-05 | 2007-03-29 | Commonwealth Scientific And Industrial Research Organisation | Viral peptides with structural homology to protein G of respiratory syncytial virus |
| AUPO026596A0 (en) * | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
-
1998
- 1998-09-17 CA CA002302833A patent/CA2302833C/en not_active Expired - Fee Related
- 1998-09-17 WO PCT/US1998/019656 patent/WO1999014334A1/en not_active Ceased
- 1998-09-17 PT PT98949392T patent/PT1015595E/pt unknown
- 1998-09-17 AU AU95725/98A patent/AU751022B2/en not_active Ceased
- 1998-09-17 BR BR9812240-1A patent/BR9812240A/pt not_active Application Discontinuation
- 1998-09-17 AT AT98949392T patent/ATE287957T1/de not_active IP Right Cessation
- 1998-09-17 ES ES98949392T patent/ES2236946T3/es not_active Expired - Lifetime
- 1998-09-17 DE DE69828801T patent/DE69828801T2/de not_active Expired - Fee Related
- 1998-09-17 KR KR1020007002861A patent/KR100550132B1/ko not_active Expired - Fee Related
- 1998-09-17 JP JP2000511872A patent/JP2001516583A/ja not_active Withdrawn
- 1998-09-17 EP EP98949392A patent/EP1015595B1/en not_active Expired - Lifetime
- 1998-09-17 CN CNB988104911A patent/CN1259422C/zh not_active Expired - Fee Related
-
2005
- 2005-02-24 CY CY20051100274T patent/CY1105010T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1259422C (zh) | 2006-06-14 |
| DE69828801D1 (de) | 2005-03-03 |
| AU9572598A (en) | 1999-04-05 |
| KR100550132B1 (ko) | 2006-02-08 |
| CA2302833C (en) | 2007-05-08 |
| JP2001516583A (ja) | 2001-10-02 |
| WO1999014334A1 (en) | 1999-03-25 |
| CN1322250A (zh) | 2001-11-14 |
| KR20010030620A (ko) | 2001-04-16 |
| DE69828801T2 (de) | 2005-07-14 |
| CA2302833A1 (en) | 1999-03-25 |
| PT1015595E (pt) | 2005-05-31 |
| AU751022B2 (en) | 2002-08-08 |
| ES2236946T3 (es) | 2005-07-16 |
| CY1105010T1 (el) | 2010-03-03 |
| EP1015595A1 (en) | 2000-07-05 |
| EP1015595B1 (en) | 2005-01-26 |
| ATE287957T1 (de) | 2005-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69829668D1 (de) | Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe | |
| HU226214B1 (en) | Vaccines with an ltb adjuvant | |
| BR9814473A (pt) | Imunógenos anti-retrovirais, preparação e uso | |
| JP2002525099A5 (enExample) | ||
| EP1064024A4 (en) | VACCINES AGAINST CIRCOVIRUS INFECTIONS | |
| WO2001045639A3 (en) | Methods for protecting against lethal infection with bacillus anthracis | |
| CA2014033A1 (en) | Compositions and treatments for pneumonia in animals | |
| ATE287957T1 (de) | Peptide abgeleitet vom bindungs (g) protein des respiratorisches synzytialvirus | |
| ATE103297T1 (de) | Peptid, immunogene zusammensetzung und impfstoff oder medizinische zubereitung, eine methode zur immunisierung eines saeugetieres gegen lhrh und methode zur verbesserung von mea. | |
| JP2001516583A5 (enExample) | ||
| JP2023503058A (ja) | ヘモフィルス・パラスイスに対する新規ワクチン | |
| DK0791063T3 (da) | Bærerprotein med adjuvansvirkning, immunogent kompleks omfattende det, fremgangsmåde til fremstilling deraf, nukleotidsekvens og vaccine | |
| FI924457A0 (fi) | Kompositioner och behandlingsfoerfarande foer lunginflammation i djur | |
| KR970703428A (ko) | Hcmv 및 hsv로부터의 융합 당단백질(fusion glycoprotein from hcmv and hsv) | |
| WO1999051188A3 (en) | A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof | |
| PE20010237A1 (es) | GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS | |
| CA2516661A1 (en) | M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever | |
| Menon et al. | Mycobacterial ESAT-6 protein enhances mouse IFN-γ responses to Mycoplasma hyopneumoniae P71 protein | |
| CA2277999A1 (en) | The 74 kilodalton outer membrane protein from moraxella catarrhalis | |
| DE69928947D1 (de) | Moraxella catarrhalis basb034 polypeptide und verwendungen davon | |
| FR2809960B1 (fr) | Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante | |
| BR0110791A (pt) | Composição, métodos para induzir uma resposta imune em um indivìduo contra um imunogene, para modular o sistema imune de um indivìduo e para imunizar um indivìduo contra um patógeno, vacina recombinante, e patógeno atenuado vivo | |
| KR950704494A (ko) | 수두-대상포진 바이러스(vzv)에 대한 백신(vaccines against varicellazoster virus(vzv)) | |
| ATE305941T1 (de) | Impfstoff | |
| NZ512448A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. |